Galena Biopharma, Inc. 4
4 · Galena Biopharma, Inc. · Filed Nov 15, 2016
Insider Transaction Report
Form 4
Ghiglieri Stephen F
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2016-11-01+1,000,000→ 1,000,000 totalExercise: $0.19Exp: 2026-11-01→ Common Stock (1,000,000 underlying)
Footnotes (3)
- [F1]Granted pursuant to the Issuer's 2016 Incentive Plan.
- [F2]The Reporting Person obtained the securities pursuant to a new hire Employment Agreement dated November 1, 2016. The securities were convertible into common stock at the rate of 1 share of common stock for each 1 stock option share, or an aggregate 1,000,000 shares of common stock (pre-reverse stock split). The securities were converted into 50,000 stock options at a price of $3.80 (post-reverse stock split) as of November 14, 2016.
- [F3]This stock option vests in equal, quarterly installments over four years, beginning three months after November 1, 2016.